Learn More
Medchemexpress LLC 2-[(1R)-1-[2-[4-methoxy-3-(2-morpholin-4-ylethoxy)phenyl]-5-methyl-1,3-thiazol-4-yl]ethyl]sulfanyl | 2107280-55-5 | MFCD34469884 | 99.5% | C23H30N6O3S2 | 10MG

Supplier: Medchemexpress LLC HY13314110MG
DI-87 is an orally active, selective deoxycytidine kinase (dCK) inhibitor developed for anticancer research. It exhibits potent biochemical activity in the low-nanomolar range and has demonstrated antitumor effects in preclinical models, where it is used to enhance the efficacy of nucleoside analog therapies.
- Potent dCK inhibition with low-nanomolar EC50.
- Orally bioavailable and metabolically stable for in vivo studies.
- Demonstrated antitumor activity in preclinical tumor models.
- Enhances efficacy of nucleoside analog therapies in combination studies.
- Supplied as a stable powder, soluble in DMSO for assay preparation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.